PYRAFAT

This brand name is authorized in Austria, Germany, Estonia, Hong Kong, Lithuania, Malta

Active ingredients

The drug PYRAFAT contains one active pharmaceutical ingredient (API):

1 Pyrazinamide
UNII 2KNI5N06TI - PYRAZINAMIDE

Pyrazinamide exhibits tuberculostatic activity. Pyrazinamide is active only at an acid pH, and it is therefore active mainly on the tubercle bacilli located within the cell.

Read about Pyrazinamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J04AK01 Pyrazinamide J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AK Other drugs for treatment of tuberculosis
Discover more medicines within J04AK01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 07568413, 07568436
Country: EE Ravimiamet Identifier(s): 1180189
Country: HK Department of Health Drug Office Identifier(s): 34750
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1001644, 1016285
Country: MT Medicines Authority Identifier(s): AA729/24901

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.